462 related articles for article (PubMed ID: 31261440)
1. Hidradenitis suppurativa and polycystic ovarian syndrome: Systematic review and meta-analysis.
Phan K; Charlton O; Smith SD
Australas J Dermatol; 2020 Feb; 61(1):e28-e33. PubMed ID: 31261440
[TBL] [Abstract][Full Text] [Related]
2. Pyoderma gangrenosum, acne, suppurative hidradenitis (PASH) and polycystic ovary syndrome: Coincidentally or aetiologically connected?
Zivanovic D; Masirevic I; Ruzicka T; Braun-Falco M; Nikolic M
Australas J Dermatol; 2017 May; 58(2):e54-e59. PubMed ID: 26831949
[TBL] [Abstract][Full Text] [Related]
3. Hidradenitis Suppurativa Is Associated with Polycystic Ovary Syndrome: A Population-Based Analysis in the United States.
Garg A; Neuren E; Strunk A
J Invest Dermatol; 2018 Jun; 138(6):1288-1292. PubMed ID: 29378201
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of polycystic ovarian syndrome among children and adolescents with hidradenitis suppurativa.
Mastacouris N; Strunk A; Garg A
J Am Acad Dermatol; 2023 Aug; 89(2):425-427. PubMed ID: 37121475
[No Abstract] [Full Text] [Related]
5. Hidradenitis suppurativa and association with stroke: systematic review and meta-analysis.
Phan K; Ng WHS; Lai B; Garg A; Smith SD
J Dermatolog Treat; 2022 Jun; 33(4):2309-2316. PubMed ID: 34289795
[TBL] [Abstract][Full Text] [Related]
6. Hidradenitis suppurativa and diabetes mellitus: A systematic review and meta-analysis.
Bui TL; Silva-Hirschberg C; Torres J; Armstrong AW
J Am Acad Dermatol; 2018 Feb; 78(2):395-402. PubMed ID: 29056237
[TBL] [Abstract][Full Text] [Related]
7. Association between Hidradenitis Suppurativa and Inflammatory Arthritis: A Systematic Review and Meta-Analysis.
Almuhanna N; Finstad A; Alhusayen R
Dermatology; 2021; 237(5):740-747. PubMed ID: 33774640
[TBL] [Abstract][Full Text] [Related]
8. Hidradenitis suppurativa, a review of pathogenesis, associations and management. Part 2.
Vekic DA; Cains GD
Australas J Dermatol; 2018 Nov; 59(4):261-266. PubMed ID: 29363099
[TBL] [Abstract][Full Text] [Related]
9. Endocrinologic Aspects of Hidradenitis Suppurativa.
Karagiannidis I; Nikolakis G; Zouboulis CC
Dermatol Clin; 2016 Jan; 34(1):45-9. PubMed ID: 26617357
[TBL] [Abstract][Full Text] [Related]
10. Risk of psoriasis in people with hidradenitis suppurativa: A systematic review and meta-analysis.
Gau SY; Preclaro IAC; Wei JC; Lee CY; Kuan YH; Hsiao YP; Juang SE; Ma KS
Front Immunol; 2022; 13():1033844. PubMed ID: 36532043
[TBL] [Abstract][Full Text] [Related]
11. Hidradenitis suppurativa and metabolic syndrome - systematic review and adjusted meta-analysis.
Phan K; Charlton O; Smith SD
Int J Dermatol; 2019 Oct; 58(10):1112-1117. PubMed ID: 31148159
[TBL] [Abstract][Full Text] [Related]
12. Risk of liver dysfunction and non-alcoholic fatty liver diseases in people with hidradenitis suppurativa: A systematic review and meta-analysis of real-world evidences.
Gau SY; Hsiao YP; Liao WC; Ma KS; Wu MC
Front Immunol; 2022; 13():959691. PubMed ID: 36591267
[TBL] [Abstract][Full Text] [Related]
13. Hidradenitis Suppurativa and Thyroid Disease: Systematic Review and Meta-Analysis.
Phan K; Huo YR; Charlton O; Smith SD
J Cutan Med Surg; 2020; 24(1):23-27. PubMed ID: 31994934
[TBL] [Abstract][Full Text] [Related]
14. Association between hidradenitis suppurativa, depression, anxiety, and suicidality: A systematic review and meta-analysis.
Patel KR; Lee HH; Rastogi S; Vakharia PP; Hua T; Chhiba K; Singam V; Silverberg JI
J Am Acad Dermatol; 2020 Sep; 83(3):737-744. PubMed ID: 31862404
[TBL] [Abstract][Full Text] [Related]
15. Hidradenitis Suppurativa in Down Syndrome: A Case Series.
Hamadah I; Haider M; Chisti M; Binamer Y
Pediatr Dermatol; 2017 Jul; 34(4):461-464. PubMed ID: 28636122
[TBL] [Abstract][Full Text] [Related]
16. The prevalence and odds of anxiety and depression in children and adults with hidradenitis suppurativa: Systematic review and meta-analysis.
Jalenques I; Ciortianu L; Pereira B; D'Incan M; Lauron S; Rondepierre F
J Am Acad Dermatol; 2020 Aug; 83(2):542-553. PubMed ID: 32222447
[TBL] [Abstract][Full Text] [Related]
17. Comorbidity screening in hidradenitis suppurativa: Evidence-based recommendations from the US and Canadian Hidradenitis Suppurativa Foundations.
Garg A; Malviya N; Strunk A; Wright S; Alavi A; Alhusayen R; Alikhan A; Daveluy SD; Delorme I; Goldfarb N; Gulliver W; Hamzavi I; Jaleel T; Kimball AB; Kirby JS; Kirchhof MG; Lester J; Lev-Tov H; Lowes MA; Micheletti R; Orenstein LA; Piguet V; Sayed C; Tan J; Naik HB
J Am Acad Dermatol; 2022 May; 86(5):1092-1101. PubMed ID: 33493574
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular disease risk factors in patients with hidradenitis suppurativa: a systematic review and meta-analysis of observational studies.
Tzellos T; Zouboulis CC; Gulliver W; Cohen AD; Wolkenstein P; Jemec GB
Br J Dermatol; 2015 Nov; 173(5):1142-55. PubMed ID: 26153913
[TBL] [Abstract][Full Text] [Related]
19. Integrating complement into the molecular pathogenesis of Hidradenitis Suppurativa.
Grand D; Navrazhina K; Frew JW
Exp Dermatol; 2020 Jan; 29(1):86-92. PubMed ID: 31688984
[TBL] [Abstract][Full Text] [Related]
20. Phenotypes and Pathophysiology of Syndromic Hidradenitis Suppurativa: Different Faces of the Same Disease? A Systematic Review.
Nikolakis G; Kaleta KP; Vaiopoulos AG; Wolter K; Baroud S; Wojas-Pelc A; Zouboulis CC
Dermatology; 2021; 237(5):673-697. PubMed ID: 32942279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
